Understanding the Recent Amendments to Tennessee's Controlled Substance Monitoring Database

The Tennessee Controlled Substance Monitoring Database (CSMD) has undergone recent amendments, which aim to improve prescription drug monitoring and reduce the misuse of controlled substances. As a healthcare practitioner or individual seeking information about these changes, it is essential to stay informed about the new regulations.

One of the key changes is the addition of Schedule II amphetamines to the list of drugs that trigger a check in the CSMD. This means that authorized healthcare practitioners' delegates can now check the controlled substance database on behalf of the prescribing healthcare practitioner for these medications, just like they do for opioids and benzodiazepines.

The amendment requires all healthcare practitioners, unless exempted, to check the CSMD prior to issuing a Schedule II amphetamine prescription. This includes checking the database at the beginning of a new episode of treatment, as well as every 6 months during that course of treatment, up to the first 90 days. This added layer of monitoring aims to identify potential abuse and ensure responsible prescribing practices.

It is also important for healthcare practitioners to note that the CSMD rules have been amended effective January 26, 2022. For more information on these changes or any other questions you may have, SVMIC is available by email at ' ' or by phone at (800) 342-2239.

For further guidance, you can also contact your state's licensure board for additional information. By staying up-to-date with the latest developments in prescription drug monitoring and compliance, healthcare practitioners can help ensure patient safety and promote responsible prescribing practices.

The links to each state's Prescription Drug Monitoring Program (PDMP/CSMD) information are provided below, providing easy access to this crucial information:

By understanding these changes and taking steps to comply with the new regulations, healthcare practitioners can help reduce the risk of controlled substance misuse and promote a safer prescribing environment for all patients.

Total words: 479

Tn pmp